Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
DISH Network Corp. (NASDAQ: DISH) shares declined 1.69 percent to close at $46.05 a share Tuesday. The stock traded between $45.60 and $46.63 on volume of 3.23 million shares traded. Analysts at Moffett Research have recently downgraded the company’s rating to "neutral" from "buy". Shares of DISH Network have gained approximately 26.0 percent year-to-date.
Find out more about DISH Network including full access to the free equity report at:
DIRECTV (NASDAQ: DTV) shares declined 2.65 percent to close at $60.64 a share Tuesday. The stock traded between $60.60and $62.16 on volume of 5.45 million shares traded. Analysts at Moffett Research have recently downgraded the company’s rating to "neutral" from "buy". Shares of DIRECTV have gained approximately 20.0 percent year-to-date.
Find out more about DIRECTV including full access to the free equity report at:
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares declined 4.63 percent to close at $18.31 a share Tuesday. The stock traded between $18.29 and $19.17 on volume of 935,799 shares traded. Analysts at William Blair have recently initiated coverage on the company with a "market perform" rating and a price target of $21.00. Shares of Infinity Pharmaceuticals have fallen approximately 47.0 percent year-to-date.
Find out more about Infinity Pharmaceuticals including full access to the free equity report at:
Microchip Technology Inc. (NASDAQ: MCHP) shares increased 1.51 percent to close at $40.94 a share Tuesday. The stock traded between $40.51 and $41.13 on volume of 1.67 million shares traded. Analysts at Goldman Sachs have recently upgraded the company’s rating to "buy" from "neutral". Shares of Microchip Technology have gained approximately 25.0 percent year-to-date.
Find out more about Microchip Technology including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing